Live Breaking News & Updates on காரேமஸ் மருத்துவ குழு
Stay updated with breaking news from காரேமஸ் மருத்துவ குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DLA Piper advises CareMax in business combination with Deerfield Healthcare Technology Acquisitions Corp. prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
05.06.2021 - Deerfield Healthcare Technology Acquisitions Corp. ( DFHT ) (NASDAQ: DFHT; DFHTW; DFHTU), a special purpose acquisition company sponsored by an affiliate of Deerfield Management Company, L.P. (“Deerfield”) and Richard Barasch, a veteran healthcare . Seite 1 ....
Chamath Files 4 New Biotech SPACs Today s SPAC highlight came post market as Chamath dropped four new SPAC S-1s for $800M total. JWS vote passes, with TSIA and JIH set to vote tomorrow. Author: In another win on Day-1 of new De-SPAC ticker trading, BARK, which just closed its merger with Northern Star Acquisition Co. (STIC) rose nearly 7%. One more example of a recent De-SPAC that has traded up shortly after, following SOFI early this week and others last month. Investors will be sure to watch this price action for future De-SPACs, and, with over 20 this month there are plenty to keep an eye out for (list below). ....
June will be a busy month of SPAC deal votes and, likely, little other activity. But, could the narrative change if de-SPAC performance outperforms expectations? ....
SPAC IPOs Mixed, DCRN Deal Slightly Rises, IPOE/SoFi Up Next IPOE fell ahead of its vote tomorrow, while DCRN rose slightly on its deal with Tritium. Of today s SPAC IPOs: 1 rose, and 2 fell. Author: This morning Decarbonization Plus II (DCRN) announced a deal to take Tritium, an Australian EV charge company, public in a $1.4B SPAC deal. The deal has no PIPE and they currently have $403M in trust. The market was, somewhat, pleased with the deal as DCRN rose modestly +1.4%, though it still trades at a sizable discount to NAV at $9.79. This represents a potential ~6% yield opportunity if you believe that the deal vote (when an investor could redeem its shares) happens within ~4-6 months. ....